Is point-of-care (POC) glycated hemoglobin (A1c) testing the best choice for diabetes screening? The option is an attractive ...

Share on Pinterest Getty Images/Dragoljub Bankovic The FreeStyle Libre is a continuous glucose monitoring (CGM) system that doesn’t require a blood sample from a finger stick. It’s ...

In the past 5 years, what change has had the greatest impact on HbA1c in diabetes care? Is it continuous glucose monitoring?

The global glucose sensor market is projected to witness substantial growth, reaching a valuation of USD 20,421.4 million by 2034, according to a recent report. The market, currently valued at USD ...

However, the nature of a point-by-point probing characteristic limits their efficiency in the measurement of complex parts, which normally requires dense sampling points for fully evaluating machining ...

With projected growth to US$ 68.5 billion by 2030, the POC diagnostics market presents significant opportunities. Companies ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

If you are interested in taking a test not currently offered, please contact KSU Academic and Professional Testing Services at 470-578-4800 or by email at ksutesting@kennesaw.edu. We continually ...

Spencer Rattler takes QB reps with starters in Thursday's OTA workout ...

Billy Evans, partner of Theranos founder Elizabeth Holmes, is working on a new startup that seeks to deliver “human health optimization” through blood testing, according to The New York Times.

The company is aiming to raise $50 million to reach their target of "human health optimization," and Evans has already raised millions in hopes of creating a medical testing product, according to ...

Introduction Human papillomavirus (HPV) self-sampling test kits may increase screening for and early detection of cervical cancer and reduce its burden globally. To inform WHO self-care guidelines, we ...